Usefulness of dynamic MRI enhancement measures for the diagnosis of ACTH-producing pituitary adenomas

Qinghua Guo, William Francis Young, Dana Erickson, Bradley J Erickson

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Purpose The distinction between corticotropin (ACTH)-producing pituitary adenomas and occult ectopic ACTH neoplasms is a challenge and frequently complicated by the detection of nonfunctioning pituitary adenomas on dynamic magnetic resonance imaging (DMRI). Herein, we explored quantitative differences in DMRI measures from ACTH-producing pituitary adenomas. Materials and methods Fifty-five patients with pathology confirmed ACTH-producing and 44 with nonfunctioning pituitary adenomas were analysed in this retrospective pilot study. The intensities of adenomas and of adjacent pituitary tissue were measured by drawing a region of interest. Time-intensity curves were then constructed, and quantitative analysis included: enhancement time, enhancement peak and prepeak slope (PPS). Multivariable logistic analysis and receiver operating characteristic curves (ROC) were used to evaluate the parameters. Results Quantitative analysis showed that tumour PPS in ACTH-producing adenomas was markedly lower than that in nonfunctioning adenomas (P = 0·0042) and that the PPS of the adjacent pituitary gland was not different (P = 0·2441). The PPS was >3·0 in 59·1% of nonfunctioning adenomas and ≤3·0 in 69·1% of ACTH-producing adenomas (P = 0·0049). Logistic analysis revealed lower tumour PPS levels (P = 0·0123, OR 1·24, 95% CI: 1·05-1·52) were associated with ACTH-producing adenomas. The optimal PPS cut-off determined by ROC analysis was 2·89, with a sensitivity of 69% and specificity of 70%. No significant difference was found between the two groups in enhancement time or enhancement peak. Conclusion Enhancement parameters in DMRI can help distinguishing ACTH producing from nonfunctioning pituitary adenomas, which could be useful in the differential diagnosis between ACTH-producing pituitary adenomas and ectopic ACTH syndrome complicated with nonfunctioning pituitary adenoma.

Original languageEnglish (US)
Pages (from-to)267-273
Number of pages7
JournalClinical Endocrinology
Volume82
Issue number2
DOIs
StatePublished - Feb 1 2015

Fingerprint

ACTH-Secreting Pituitary Adenoma
Adrenocorticotropic Hormone
Adenoma
Pituitary Neoplasms
Magnetic Resonance Imaging
ROC Curve
Ectopic ACTH Syndrome
Neoplasms
Pituitary Gland
Differential Diagnosis
Retrospective Studies
Pathology
Sensitivity and Specificity

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Cite this

Usefulness of dynamic MRI enhancement measures for the diagnosis of ACTH-producing pituitary adenomas. / Guo, Qinghua; Young, William Francis; Erickson, Dana; Erickson, Bradley J.

In: Clinical Endocrinology, Vol. 82, No. 2, 01.02.2015, p. 267-273.

Research output: Contribution to journalArticle

@article{25cc501f479045c48d9e3048719465b4,
title = "Usefulness of dynamic MRI enhancement measures for the diagnosis of ACTH-producing pituitary adenomas",
abstract = "Purpose The distinction between corticotropin (ACTH)-producing pituitary adenomas and occult ectopic ACTH neoplasms is a challenge and frequently complicated by the detection of nonfunctioning pituitary adenomas on dynamic magnetic resonance imaging (DMRI). Herein, we explored quantitative differences in DMRI measures from ACTH-producing pituitary adenomas. Materials and methods Fifty-five patients with pathology confirmed ACTH-producing and 44 with nonfunctioning pituitary adenomas were analysed in this retrospective pilot study. The intensities of adenomas and of adjacent pituitary tissue were measured by drawing a region of interest. Time-intensity curves were then constructed, and quantitative analysis included: enhancement time, enhancement peak and prepeak slope (PPS). Multivariable logistic analysis and receiver operating characteristic curves (ROC) were used to evaluate the parameters. Results Quantitative analysis showed that tumour PPS in ACTH-producing adenomas was markedly lower than that in nonfunctioning adenomas (P = 0·0042) and that the PPS of the adjacent pituitary gland was not different (P = 0·2441). The PPS was >3·0 in 59·1{\%} of nonfunctioning adenomas and ≤3·0 in 69·1{\%} of ACTH-producing adenomas (P = 0·0049). Logistic analysis revealed lower tumour PPS levels (P = 0·0123, OR 1·24, 95{\%} CI: 1·05-1·52) were associated with ACTH-producing adenomas. The optimal PPS cut-off determined by ROC analysis was 2·89, with a sensitivity of 69{\%} and specificity of 70{\%}. No significant difference was found between the two groups in enhancement time or enhancement peak. Conclusion Enhancement parameters in DMRI can help distinguishing ACTH producing from nonfunctioning pituitary adenomas, which could be useful in the differential diagnosis between ACTH-producing pituitary adenomas and ectopic ACTH syndrome complicated with nonfunctioning pituitary adenoma.",
author = "Qinghua Guo and Young, {William Francis} and Dana Erickson and Erickson, {Bradley J}",
year = "2015",
month = "2",
day = "1",
doi = "10.1111/cen.12475",
language = "English (US)",
volume = "82",
pages = "267--273",
journal = "Clinical Endocrinology",
issn = "0300-0664",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Usefulness of dynamic MRI enhancement measures for the diagnosis of ACTH-producing pituitary adenomas

AU - Guo, Qinghua

AU - Young, William Francis

AU - Erickson, Dana

AU - Erickson, Bradley J

PY - 2015/2/1

Y1 - 2015/2/1

N2 - Purpose The distinction between corticotropin (ACTH)-producing pituitary adenomas and occult ectopic ACTH neoplasms is a challenge and frequently complicated by the detection of nonfunctioning pituitary adenomas on dynamic magnetic resonance imaging (DMRI). Herein, we explored quantitative differences in DMRI measures from ACTH-producing pituitary adenomas. Materials and methods Fifty-five patients with pathology confirmed ACTH-producing and 44 with nonfunctioning pituitary adenomas were analysed in this retrospective pilot study. The intensities of adenomas and of adjacent pituitary tissue were measured by drawing a region of interest. Time-intensity curves were then constructed, and quantitative analysis included: enhancement time, enhancement peak and prepeak slope (PPS). Multivariable logistic analysis and receiver operating characteristic curves (ROC) were used to evaluate the parameters. Results Quantitative analysis showed that tumour PPS in ACTH-producing adenomas was markedly lower than that in nonfunctioning adenomas (P = 0·0042) and that the PPS of the adjacent pituitary gland was not different (P = 0·2441). The PPS was >3·0 in 59·1% of nonfunctioning adenomas and ≤3·0 in 69·1% of ACTH-producing adenomas (P = 0·0049). Logistic analysis revealed lower tumour PPS levels (P = 0·0123, OR 1·24, 95% CI: 1·05-1·52) were associated with ACTH-producing adenomas. The optimal PPS cut-off determined by ROC analysis was 2·89, with a sensitivity of 69% and specificity of 70%. No significant difference was found between the two groups in enhancement time or enhancement peak. Conclusion Enhancement parameters in DMRI can help distinguishing ACTH producing from nonfunctioning pituitary adenomas, which could be useful in the differential diagnosis between ACTH-producing pituitary adenomas and ectopic ACTH syndrome complicated with nonfunctioning pituitary adenoma.

AB - Purpose The distinction between corticotropin (ACTH)-producing pituitary adenomas and occult ectopic ACTH neoplasms is a challenge and frequently complicated by the detection of nonfunctioning pituitary adenomas on dynamic magnetic resonance imaging (DMRI). Herein, we explored quantitative differences in DMRI measures from ACTH-producing pituitary adenomas. Materials and methods Fifty-five patients with pathology confirmed ACTH-producing and 44 with nonfunctioning pituitary adenomas were analysed in this retrospective pilot study. The intensities of adenomas and of adjacent pituitary tissue were measured by drawing a region of interest. Time-intensity curves were then constructed, and quantitative analysis included: enhancement time, enhancement peak and prepeak slope (PPS). Multivariable logistic analysis and receiver operating characteristic curves (ROC) were used to evaluate the parameters. Results Quantitative analysis showed that tumour PPS in ACTH-producing adenomas was markedly lower than that in nonfunctioning adenomas (P = 0·0042) and that the PPS of the adjacent pituitary gland was not different (P = 0·2441). The PPS was >3·0 in 59·1% of nonfunctioning adenomas and ≤3·0 in 69·1% of ACTH-producing adenomas (P = 0·0049). Logistic analysis revealed lower tumour PPS levels (P = 0·0123, OR 1·24, 95% CI: 1·05-1·52) were associated with ACTH-producing adenomas. The optimal PPS cut-off determined by ROC analysis was 2·89, with a sensitivity of 69% and specificity of 70%. No significant difference was found between the two groups in enhancement time or enhancement peak. Conclusion Enhancement parameters in DMRI can help distinguishing ACTH producing from nonfunctioning pituitary adenomas, which could be useful in the differential diagnosis between ACTH-producing pituitary adenomas and ectopic ACTH syndrome complicated with nonfunctioning pituitary adenoma.

UR - http://www.scopus.com/inward/record.url?scp=84921545790&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921545790&partnerID=8YFLogxK

U2 - 10.1111/cen.12475

DO - 10.1111/cen.12475

M3 - Article

C2 - 24801354

AN - SCOPUS:84921545790

VL - 82

SP - 267

EP - 273

JO - Clinical Endocrinology

JF - Clinical Endocrinology

SN - 0300-0664

IS - 2

ER -